Report in English with a Dutch summary (KCE reports 45A)

KCE reports vol.45 Screening for Colorectal Cancer 219
20. Marshall KG. Population-based fecal occult blood screening for colon cancer: will the
benefits outweigh the harm? CMAJ. 2000;163(5):545-6; discussion 7.
21. Parker MA, Robinson MHE, Scholefield JH, Hardcastle JD. Psychiatric morbidity and
screening for colorectal cancer. Journal of Medical Screening. 2002;9(1):7-10.
22. Salkeld G, Solomon M, Short L, Ryan M, Ward JE. Evidence-based consumer choice:
a case study in colorectal cancer screening. Aust N Z J Public Health.
2003;27(4):449-55.
23. Madlensky L, McLaughlin JR, Carroll JC, Goel V, Frank JW. Risks and benefits of
population-based genetic testing for Mendelian subsets of common diseases were
examined using the example of colorectal cancer risk. J Clin Epidemiol.
2005;58(9):934-41.
24. Towler BP, Irwig L, Glasziou P, Weller D, Kewenter J. Screening for colorectal
cancer using the faecal occult blood test, Hemoccult. Cochrane Database of
Systematic Reviews. 2005;2:2.
25. Thiis-Evensen E, Wilhelmsen I, Hoff GS, Blomhoff S, Sauar J. The psychologic effect
of attending a screening program for colorectal polyps. Scand J Gastroenterol.
1999;34(1):103-9.
26. Ahmed S, Leslie A, Thaha MA, Carey FA, Steele RJC. Lower gastrointestinal
symptoms are not predictive of colorectal neoplasia in a faecal occult blood screenpositive
population. British Journal of Surgery. 2005;92(4):478-81.
27. NZGC. Surveillance and management of groups at increased risk of colorectal
cancer. New Zealand Guidelines Group. 2004.
28. Canadian Task Force on Preventive Health Care. Colorectal cancer screening.
Recommendation statement from the Canadian Task Force on Preventive Health
Care. CMAJ. 2001;165(2):206-8.
29. Cairns S, Scholefield JH. Guidelines for colorectal cancer screening in high risk
groups. Gut. 2002;51 Suppl 5(51):V1-2.
30. Steele RJ. Fecal occult blood test screening in the United kingdom. Am J
Gastroenterol. 2006;101(2):216-8.
31. Gyrd-Hansen D, Sogaard J. Analysing Public Preferences for Cancer Screening
Programmes. Health Economics. 2001;10(7):617-34.
32. WHO. WHO - Family of International Classifications. 2006.
33. CDC. International Classification of Diseases, 9th Revision, Clinical Modification
(ICD-9-CM). 2006.
34. Boyle P, Langman JS. ABC of colorectal cancer: Epidemiology. BMJ.
2000;321(7264):805-8.
35. Boyle P, Ferlay J. Mortality and survival in breast and colorectal cancer. Nat Clin
Pract Oncol. 2005;2(9):424-5.
36. Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Annals of
Oncology March. 2005;16(3):481-8.
37. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Results of
screening colonoscopy among persons 40 to 49 years of age. N Engl J Med.
2002;346(23):1781-5.
38. NCI. Colorectal Cancer (PDQ®): Prevention - Health Professional Version - Update
2006-05-22. PDQ® - NCI's Comprehensive Cancer Database. 2006.
39. Van Eycken E, De Wever N. Cancer Incidence and Survival in Flanders, 2000-2001.
Flemish Cancer Registry Network. 2006;VLK, Brussels, 2006.
40. American Cancer Society. Patient pages. Colorectal cancer staging. CA Cancer J
Clin. 2004;54(6):362-5.
41. Compton CC, Greene FL. The staging of colorectal cancer: 2004 and beyond. CA
Cancer J Clin. 2004;54(6):295-308.
42. Dukes CE. The classification of cancer of the rectum. J. Pathol. Bacteriolog.
1932(32):323-32.